App-delivered Sleep ThERapy for Older Individuals With Insomnia

NCT05067569 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 270

Last updated 2025-12-22

No results posted yet for this study

Summary

This randomised, open, parallel controlled trial aims to compare the efficacy of a digital brief behavioural therapy for insomnia (dBBTi) against online sleep health education on insomnia symptom severity in older adults aged 60 years and over. The trial will be totally online with participants recruited from the community across Australia.

Conditions

Interventions

BEHAVIORAL

SleepFix mobile application

The SleepFix app is a novel, innovative way to deliver digital brief behavioural therapy for insomnia for adults.

BEHAVIORAL

Sleep Health Education

These internet-based modules provide an active control intervention consisting of 3 modules provided bi-weekly. The participant will receive a link to this information as each module is made available. Control participants will have full access to these modules for the duration of the study. They reflect basic educational information regarding sleep health for poor sleepers that is otherwise easily accessible on the internet.

Sponsors & Collaborators

  • University of Sydney

    collaborator OTHER
  • Woolcock Institute of Medical Research

    lead OTHER

Principal Investigators

  • Ronald Grunstein, MD, PhD · Woolcock Institute of Medical Research

  • Christopher Gordon, PhD · University of Sydney

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-10-01
Primary Completion
2025-01-31
Completion
2025-04-30

Countries

  • Australia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05067569 on ClinicalTrials.gov